
Paxlovid helped a lot of people get over COVID faster. But what about the people who never got better?
A large NIH-funded trial put that question to the test in almost 1,000 people, and the answer was no.
The 89% reduction that made Paxlovid famous came out of a narrow, high-risk group back in 2021, during the Delta wave. That was a different question, in a different group, at a different point in the pandemic. Evan H. Hirsch, MD, breaks down what the RECOVER-VITAL trial actually found after six months, why trials at Yale and Stanford landed in the same place, and what the drug was designed to do from the start. He also gets into what else is keeping you sick: the spike protein appears to wake up viruses that have been dormant inside you for years, and he shares how a client who took Paxlovid twice only got better once all of the Toxic 5 were addressed.
In this episode, you'll learn:
- What Paxlovid was actually approved for, and why the famous 89% reduction in hospitalizations came out of a narrow, high-risk group during the 2021 Delta wave
- What the NIH-funded RECOVER-VITAL trial found when almost 1,000 people took extended Paxlovid for six months, and why trials at Yale and Stanford found the same thing
- Why the drug is safe to take for that long but still cannot resolve Long COVID on its own
- How the spike protein appears to wake up viruses like Epstein-Barr and HHV6 that over 90% of us already carry, and why a new trial at Mount Sinai is stacking antivirals because of it
- What the Toxic 5 are, and how a client who took Paxlovid twice recovered only after all five root causes were addressed
- How a client recovered by addressing all five root causes together, not just the reactivated virus driving her brain fog
- Discover your fatigue score and the root causes keeping you stuck: https://myfatiguescore.com
- Free Fatigue Masterclass: https://fixyourfatigue.com
- See real results: https://energymdmethod.com/results
Chapters:
00:00 - Introduction
00:38 - What Paxlovid Is and What It Was Made For
01:53 - Can Paxlovid Help the Chronic Version?
02:19 - What the RECOVER-VITAL Trial Found
03:13 - Why One Antiviral Was Never Enough
04:24 - The Viruses the Spike Protein Wakes Up
05:39 - Case Study: A Client's Recovery
06:43 - Where That Leaves Paxlovid
Subscribe to the EnergyMD Podcast for weekly conversations with leading experts on resolving ME/CFS and Long COVID by addressing the real root causes.
.
For more information about Evan and his program, Click Here.
Prefer to watch on Youtube? Click Here.
Please note that any information in this episode is for educational purposes only and does not constitute medical advice.
D'autres épisodes de "EnergyMD Podcast"



Ne ratez aucun épisode de “EnergyMD Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.








